檢索結果 - Xiaorui, Fu

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
    Identifying a new microRNA signature as a prognostic biomarker in colon cancer

    Identifying a new microRNA signature as a prognostic biomarker in colon cancer 由 Yunxia Lv, Jinzhong Duanmu, Xiaorui Fu, Taiyuan Li, Qunguang Jiang

    出版 2020
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Analyzing and validating the prognostic value and mechanism of colon cancer immune microenvironment

    Analyzing and validating the prognostic value and mechanism of colon cancer immune microenvironment 由 Xinyi Wang, Jinzhong Duanmu, Xiaorui Fu, Taiyuan Li, Qunguang Jiang

    出版 2020
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Identification and validation of m6A RNA methylation regulators with clinical prognostic value in Papillary thyroid cancer

    Identification and validation of m6A RNA methylation regulators with clinical prognostic value in Papillary thyroid cancer 由 Xinyi Wang, Xiaorui Fu, Junjia Zhang, Chengfeng Xiong, Shuyong Zhang, Yunxia Lv

    出版 2020
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Urinary Matrix Metalloproteinase-7 Predicts Severe AKI and Poor Outcomes after Cardiac Surgery

    Urinary Matrix Metalloproteinase-7 Predicts Severe AKI and Poor Outcomes after Cardiac Surgery 由 Xiaobing Yang, Chunbo Chen, Siyuan Teng, Xiaorui Fu, Yan Zha, Jialu Liu, Li Wang, Jianwei Tian, Xiangyan Zhang, Youhua Liu, Jing Nie, Fan Fan Hou

    出版 2017
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Discovery and validation of the tumor-suppressive function of long noncoding RNA PANDA in human diffuse large B-cell lymphoma through the inactivation of MAPK/ERK signaling pathway

    Discovery and validation of the tumor-suppressive function of long noncoding RNA PANDA in human diffuse large B-cell lymphoma through the inactivation of MAPK/ERK signaling pathway 由 Yingjun Wang, Mingzhi Zhang, Huanan Xu, Yifei Wang, Zhaoming Li, Yu Chang, Xinhuan Wang, Xiaorui Fu, Zhi‐Yuan Zhou, Siyuan Yang, Bei Wang, Yufeng Shang

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Ketogenic diet treatment for super-refractory status epilepticus in the intensive care unit: feasibility, safety and effectiveness

    Ketogenic diet treatment for super-refractory status epilepticus in the intensive care unit: feasibility, safety and effectiveness 由 Yishu Ren, Mengyao Zhang, Xiaorui Fu, Yan Zhang, Fang Liu, Chenglin Wu, Hai-Yan Shi, Fei Tian, Gang Liu, Yicong Lin, Yingying Su, Weibi Chen

    出版 2025
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Butyrate-producing<i>Faecalibacterium prausnitzii</i>suppresses natural killer/T-cell lymphoma by dampening the JAK-STAT pathway

    Butyrate-producing<i>Faecalibacterium prausnitzii</i>suppresses natural killer/T-cell lymphoma by dampening the JAK-STAT pathway 由 Zhuangzhuang Shi, Min Li, Chen Zhang, Hongwen Li, Yue Zhang, Lei Zhang, Xin Li, Ling Li, Xinhua Wang, Xiaorui Fu, Zhenchang Sun, Xu Dong Zhang, Tian Li, Mingzhi Zhang, Wei‐Hua Chen, Zhaoming Li

    出版 2024
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Myeloablative Haploidentical Transplant as an Alternative to Matched Sibling Transplant for Peripheral T-Cell Lymphomas

    Myeloablative Haploidentical Transplant as an Alternative to Matched Sibling Transplant for Peripheral T-Cell Lymphomas 由 Zhenyang, Gu, Nainong, Li, Xiaoxiong, Wu, Maihong, Wang, Xiaorui, Fu, Zhao, Wang, Hanyun, Ren, Yuhang, Li, Xiaofan, Li, Yamei, Wu, Yao, Liu, Mingzhi, Zhang, Yini, Wang, Daihong, Liu, Yujun, Dong, Liangding, Hu, Wenrong, Huang

    出版 2021
    獲取全文 獲取全文 獲取全文
    Text
    加到收藏夾
    Saved in:
  9. 9
    DDGP versus SMILE in Newly Diagnosed Advanced Natural Killer/T-Cell Lymphoma: A Randomized Controlled, Multicenter, Open-label Study in China

    DDGP versus SMILE in Newly Diagnosed Advanced Natural Killer/T-Cell Lymphoma: A Randomized Controlled, Multicenter, Open-label Study in China 由 Xin Li, Yingying Cui, Zhenchang Sun, Lei Zhang, Ling Li, Xinhua Wang, Jingjing Wu, Xiaorui Fu, Wang Ma, Xudong Zhang, Yu Chang, Feifei Nan, Wencai Li, Liping Su, Jinghua Wang, Hong‐Wei Xue, Mingzhi Zhang

    出版 2016
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma

    Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma 由 Xin Li, Yasong Cheng, Mingzhi Zhang, Jiaqin Yan, Ling Li, Xiaorui Fu, Xudong Zhang, Yu Chang, Zhenchang Sun, Hui Yu, Lei Zhang, Xinhua Wang, Jingjing Wu, Zhaoming Li, Feifei Nan, Tian Li, Wencai Li, Ken H. Young

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Recurrent PDGFRB mutations in unicentric Castleman disease

    Recurrent PDGFRB mutations in unicentric Castleman disease 由 Zhaoming Li, Xuan Lan, Chaoping Li, Yanjie Zhang, Yingjun Wang, Weili Xue, Lisha Lu, Mengyuan Jin, Zhi‐Yuan Zhou, Xinhua Wang, Ling Li, Lei Zhang, Xin Li, Xiaorui Fu, Zhenchang Sun, Jingjing Wu, Xudong Zhang, Hui Yu, Feifei Nan, Yu Chang, Jiaqin Yan, Xiaolong Wu, Guannan Wang, Dandan Zhang, Yuan Zhang, Ken H. Young, Mingzhi Zhang

    出版 2019
    獲取全文
    Carta
    加到收藏夾
    Saved in:
  12. 12
    Autologous Nanobody-Derived Fratricide-Resistant CD7-CAR T-cell Therapy for Patients with Relapsed and Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma

    Autologous Nanobody-Derived Fratricide-Resistant CD7-CAR T-cell Therapy for Patients with Relapsed and Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma 由 Mingzhi Zhang, Dan Chen, Xiaorui Fu, Huimin Meng, Feifei Nan, Zhenchang Sun, Hui Yu, Lei Zhang, Ling Li, Xin Li, Xinhua Wang, Min Wang, Fengtao You, Zhaoming Li, Yu Chang, Zhi‐Yuan Zhou, Jiaqin Yan, J Y Li, Xiaolong Wu, Yu Wang, Yinyan Wang, Shufen Xiang, Yusheng Chen, Guifang Pan, Hanying Xu, Bozhen Zhang, Lin Yang

    出版 2022
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase–Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma

    Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase–Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Ly... 由 Xinhua Wang, Lei Zhang, Xiangli Liu, Xin Li, Ling Li, Xiaorui Fu, Zhenchang Sun, Jingjing Wu, Xudong Zhang, Jiaqin Yan, Yu Chang, Feifei Nan, Zhi‐Yuan Zhou, Xiaolong Wu, Tian Li, Minrui Ma, Zhaoming Li, Hui Yu, Linan Zhu, Yingjun Wang, Cunzhen Shi, Xiaoyan Feng, J Y Li, Mengjie Ding, Jieming Zhang, Meng Dong, Hong‐Wei Xue, Jinghua Wang, Liqun Zou, Liping Su, Jianqiu Wu, Lihong Liu, Huizheng Bao, Liling Zhang, Yanzhen Guo, Shuxia Guo, Yi Lü, Ken H. Young, Wencai Li, Mingzhi Zhang

    出版 2022
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: